Sequence Bio

Sequence Bio is a biotechnology company based in Newfoundland and Labrador, focused on leveraging data-driven approaches to enhance drug discovery and development. The company's mission centers on addressing the high failure rate of drug candidates, which stands at 90%, by discovering the true signals of disease that can lead to more effective medicines. Sequence Bio utilizes a unique systems biology approach that integrates multi-omics data, real-world patient information, and well-characterized phenotypes to create discovery cohorts for both common and rare diseases.

The company emphasizes…